Search

Your search keyword '"Iwamoto, F."' showing total 152 results

Search Constraints

Start Over You searched for: Author "Iwamoto, F." Remove constraint Author: "Iwamoto, F."
152 results on '"Iwamoto, F."'

Search Results

1. 10 Toca 5: Toca 511 combined with Toca FC versus standard of care in patients undergoing planned resection for recurrent glioblastoma or anaplastic astrocytoma

4. Efficacy signals, long-term exposure and safety data from a phase 1–2 study of a cell-penetrating peptide antagonist of CEBPβ, a novel target, in patients (pts) with refractory solid tumors

10. 230 (PB110) - Efficacy signals, long-term exposure and safety data from a phase 1–2 study of a cell-penetrating peptide antagonist of CEBPβ, a novel target, in patients (pts) with refractory solid tumors

12. Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

13. Results of phase II trial of SL-701, a novel immunotherapy targeting IL-13Ra2, EphA2, and survivin, in adults with second-line recurrent glioblastoma (GBM)

17. Fungal encephalitis following bone marrow transplantation: Clinical findings and prognosis

19. Semiautomated volumetric measurement on postcontrast MR imaging for analysis of recurrent and residual disease in glioblastoma multiforme.

22. RT-13 * OPTIMIZING RADIATION THERAPY FOR GLIOBLASTOMA PATIENTS: A COMPARATIVE STUDY OF USING DIFFERENT MRI MODALITIES TO MINIMIZE RADIATION INJURY

24. Recursive partitioning analysis of prognostic variables in newly diagnosed anaplastic oligodendroglial tumors

25. IMMUNOTHERAPY/BIOLOGICAL THERAPIES

27. Response to Weltman and Fleury Malheiros, re Lassman et al.

28. Initial treatment patterns over time for anaplastic oligodendroglial tumors

29. Recursive Partitioning Analysis Identifies Prognostic Groups for Glioblastoma Patients Aged 70 Years or Older (P07.109)

30. MEDICAL AND NEURO-ONCOLOGY

32. Serum YKL-40 is a marker of prognosis and disease status in high-grade gliomas

33. International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors

36. Ongoing Clinical Trials

40. Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02)

43. Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report

Catalog

Books, media, physical & digital resources